These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

809 related items for PubMed ID: 19031219

  • 1. Serum ghrelin level in women with polycystic ovary syndrome and its relationship with endocrine and metabolic parameters.
    Mitkov M, Pehlivanov B, Orbetzova M.
    Gynecol Endocrinol; 2008 Nov; 24(11):625-30. PubMed ID: 19031219
    [Abstract] [Full Text] [Related]

  • 2. [Serum levels of ghrelin and leptin in women with polycystic ovary syndrome].
    Pekhlivanov B, Mitkov M, Orbtsova M, Terzieva D.
    Akush Ginekol (Sofiia); 2008 Nov; 47(3):15-9. PubMed ID: 18756827
    [Abstract] [Full Text] [Related]

  • 3. Serum leptin levels correlate with clinical and biochemical indices of insulin resistance in women with polycystic ovary syndrome.
    Pehlivanov B, Mitkov M.
    Eur J Contracept Reprod Health Care; 2009 Apr; 14(2):153-9. PubMed ID: 19340711
    [Abstract] [Full Text] [Related]

  • 4. The effects of oral contraceptives including low-dose estrogen and drospirenone on the concentration of leptin and ghrelin in polycystic ovary syndrome.
    Sağsöz N, Orbak Z, Noyan V, Yücel A, Uçar B, Yildiz L.
    Fertil Steril; 2009 Aug; 92(2):660-6. PubMed ID: 18973889
    [Abstract] [Full Text] [Related]

  • 5. Serum ghrelin, leptin and resistin levels in adolescent girls with polycystic ovary syndrome.
    Bideci A, Camurdan MO, Yeşilkaya E, Demirel F, Cinaz P.
    J Obstet Gynaecol Res; 2008 Aug; 34(4):578-84. PubMed ID: 18937712
    [Abstract] [Full Text] [Related]

  • 6. [Exploration of the classification of polycystic ovarian syndrome].
    Lin JF, Li X, Zhu MW.
    Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):684-8. PubMed ID: 17199924
    [Abstract] [Full Text] [Related]

  • 7. [Correlations between adipocytokines and insulin resistance in women with polycystic ovary syndrome].
    Li X, Li X, Huang HY, Ma D, Zhu MW, Lin JF.
    Zhonghua Yi Xue Za Zhi; 2009 Oct 13; 89(37):2607-10. PubMed ID: 20137676
    [Abstract] [Full Text] [Related]

  • 8. Chronic inflammation and elevated homocysteine levels are associated with increased body mass index in women with polycystic ovary syndrome.
    Guzelmeric K, Alkan N, Pirimoglu M, Unal O, Turan C.
    Gynecol Endocrinol; 2007 Sep 13; 23(9):505-10. PubMed ID: 17852421
    [Abstract] [Full Text] [Related]

  • 9. Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome.
    Ardawi MS, Rouzi AA.
    Fertil Steril; 2005 Jun 13; 83(6):1708-16. PubMed ID: 15950640
    [Abstract] [Full Text] [Related]

  • 10. The relationship between metabolic status and levels of adiponectin and ghrelin in lean women with polycystic ovary syndrome.
    Bik W, Baranowska-Bik A, Wolinska-Witort E, Chmielowska M, Martynska L, Baranowska B.
    Gynecol Endocrinol; 2007 Jun 13; 23(6):325-31. PubMed ID: 17616856
    [Abstract] [Full Text] [Related]

  • 11. Body fat composition and distribution in women with polycystic ovary syndrome.
    Cosar E, Uçok K, Akgün L, Köken G, Sahin FK, Arioz DT, Baş O.
    Gynecol Endocrinol; 2008 Aug 13; 24(8):428-32. PubMed ID: 18850379
    [Abstract] [Full Text] [Related]

  • 12. [Interrelationship of abnormal family history in the first degree relatives and clinical phenotype of patients with polycystic ovary syndrome].
    Wang Y, Mao WW, Chen YJ, Li MZ, Qiao J, Wang LN.
    Zhonghua Fu Chan Ke Za Zhi; 2007 Nov 13; 42(11):756-60. PubMed ID: 18307903
    [Abstract] [Full Text] [Related]

  • 13. Effect of long-term orlistat treatment on serum levels of advanced glycation end-products in women with polycystic ovary syndrome.
    Diamanti-Kandarakis E, Katsikis I, Piperi C, Alexandraki K, Panidis D.
    Clin Endocrinol (Oxf); 2007 Jan 13; 66(1):103-9. PubMed ID: 17201808
    [Abstract] [Full Text] [Related]

  • 14. Increased levels of serum advanced glycation end-products in women with polycystic ovary syndrome.
    Diamanti-Kandarakis E, Piperi C, Kalofoutis A, Creatsas G.
    Clin Endocrinol (Oxf); 2005 Jan 13; 62(1):37-43. PubMed ID: 15638868
    [Abstract] [Full Text] [Related]

  • 15. High sensitive serum C-reactive protein and its relationship with other cardiovascular risk factors in normoinsulinemic polycystic ovary patients without metabolic syndrome.
    Verit FF.
    Arch Gynecol Obstet; 2010 Jun 13; 281(6):1009-14. PubMed ID: 19771438
    [Abstract] [Full Text] [Related]

  • 16. Serum total L-carnitine levels in non-obese women with polycystic ovary syndrome.
    Fenkci SM, Fenkci V, Oztekin O, Rota S, Karagenc N.
    Hum Reprod; 2008 Jul 13; 23(7):1602-6. PubMed ID: 18378560
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of insulin resistance and metabolic syndrome in patients with polycystic ovary syndrome.
    Lankarani M, Valizadeh N, Heshmat R, Peimani M, Sohrabvand F.
    Gynecol Endocrinol; 2009 Aug 13; 25(8):504-7. PubMed ID: 19499403
    [Abstract] [Full Text] [Related]

  • 18. Adiponectin is an independent determinant of insulin resistance in women with polycystic ovary syndrome.
    Gulcelik NE, Aral Y, Serter R, Demir Y, Culha C.
    Gynecol Endocrinol; 2006 Sep 13; 22(9):511-5. PubMed ID: 17071536
    [Abstract] [Full Text] [Related]

  • 19. Metformin versus rosiglitazone in the treatment of polycystic ovary syndrome.
    Mitkov M, Pehlivanov B, Terzieva D.
    Eur J Obstet Gynecol Reprod Biol; 2006 May 01; 126(1):93-8. PubMed ID: 16360262
    [Abstract] [Full Text] [Related]

  • 20. [Evaluation of leptin levels in plasma and their reliance on other hormonal factors affecting tissue fat levels in people with various levels of endogenous cotisol].
    Robaczyk MG.
    Ann Acad Med Stetin; 2002 May 01; 48():283-300. PubMed ID: 14601484
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.